Literature DB >> 18808420

Regulation of TGF-beta family signaling by E3 ubiquitin ligases.

Yasumichi Inoue1, Takeshi Imamura.   

Abstract

Members of the transforming growth factor-beta (TGF-beta) family, including TGF-beta, activin and bone morphogenetic proteins (BMPs), are multifunctional proteins that regulate a wide variety of cellular responses, such as proliferation, differentiation, migration and apoptosis. Alterations in their downstream signaling pathways are associated with a range of human diseases like cancer. TGF-beta family members transduce signals through membrane serine/threonine kinase receptors and intracellular Smad proteins. The ubiquitin-proteasome pathway, an evolutionarily conserved cascade, tightly regulates TGF-beta family signaling. In this pathway, E3 ubiquitin ligases play a crucial role in the recognition and degradation of target proteins by the 26S proteasomes. Smad degradation regulates TGF-beta family signaling; HECT (homologous to the E6-accessory protein C-terminus)-type E3 ubiquitin ligases, Smad ubiquitin regulatory factor 1 (Smurf1), Smurf2, and a RING-type E3 ubiquitin ligase, ROC1-SCF(Fbw1a) have been implicated in Smad degradation. Smurf1 and Smurf2 bind to TGF-beta family receptors via the inhibitory Smads, Smad6 and Smad7, to induce their ubiquitin-dependent degradation. Arkadia, a RING-type E3 ubiquitin ligase, induces the ubiquitination and degradation of Smad7 and corepressors, c-Ski and SnoN, to enhance TGF-beta family signaling. Abnormalities in E3 ubiquitin ligases that control components of TGF-beta family signaling may lead to the development and progression of various cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18808420     DOI: 10.1111/j.1349-7006.2008.00925.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  109 in total

Review 1.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

2.  Smad7 regulates terminal maturation of chondrocytes in the growth plate.

Authors:  Kristine D Estrada; Weiguang Wang; Kelsey N Retting; Chengan T Chien; Fuad F Elkhoury; Rainer Heuchel; Karen M Lyons
Journal:  Dev Biol       Date:  2013-08-29       Impact factor: 3.582

3.  Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2.

Authors:  Dipankar Ray; Aarif Ahsan; Abigail Helman; Guoan Chen; Ashok Hegde; Susmita Ramanand Gurjar; Lili Zhao; Hiroaki Kiyokawa; David G Beer; Theodore S Lawrence; Mukesh K Nyati
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

Review 4.  TGF-β signaling in C. elegans.

Authors:  Tina L Gumienny; Cathy Savage-Dunn
Journal:  WormBook       Date:  2013-07-10

5.  JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.

Authors:  Ana Cecilia Millena; BaoHan T Vo; Shafiq A Khan
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

Review 6.  Structural determinants of Smad function in TGF-β signaling.

Authors:  Maria J Macias; Pau Martin-Malpartida; Joan Massagué
Journal:  Trends Biochem Sci       Date:  2015-04-29       Impact factor: 13.807

7.  Interaction of the RhoA exchange factor Net1 with discs large homolog 1 protects it from proteasome-mediated degradation and potentiates Net1 activity.

Authors:  Heather S Carr; Chunlin Cai; Kari Keinänen; Jeffrey A Frost
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

Review 8.  Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.

Authors:  Catherine Baugé; Nicolas Girard; Eva Lhuissier; Celine Bazille; Karim Boumediene
Journal:  Aging Dis       Date:  2013-12-17       Impact factor: 6.745

Review 9.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

Review 10.  SMAD7: a timer of tumor progression targeting TGF-β signaling.

Authors:  Lingyu Luo; Nianshuang Li; Nonghua Lv; Deqiang Huang
Journal:  Tumour Biol       Date:  2014-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.